Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Sprycel“
Suchtreffer
Begriffe & Kennungen
Sprycel · 4.8 · 50 Skin and subcutaneous tissue disorders Very common skin rashe Common alopecia, dermatitis (including eczema
Eintrag öffnenSprycel · 4.8 · 51 Description of selected adverse reactions Myelosuppression Treatment with SPRYCEL is associated with anaemi
Eintrag öffnenSprycel · 4.8 · 52 section 4.4). No additional patients were reported to have QTcF > 500 msec after a minimum of 60 months fol
Eintrag öffnenSprycel · 4.8 · 53 Table 6b: Selected adverse reactions reported in phase III dose-optimisation study: Advanced phase CML and
Eintrag öffnenSprycel · 4.8 · 54 Laboratory test abnormalities Haematology In the Phase III newly diagnosed chronic phase CML study, the fol
Eintrag öffnenSprycel · 4.8 · Approximately 5% of the SPRYCEL-treated patients who had normal baseline levels experienced grade 3 or 4 trans
Eintrag öffnenSprycel · 4.8 · Approximately 5% of the SPRYCEL-treated patients who had normal baseline levels experienced grade 3 or 4 trans
Eintrag öffnenSprycel · 4.8 · Biochemistry In the newly diagnosed chronic phase CML study, grade 3 or 4 hypophosphataemia was reported in 4%
Eintrag öffnenSprycel · 4.8 · Biochemistry In the newly diagnosed chronic phase CML study, grade 3 or 4 hypophosphataemia was reported in 4%
Eintrag öffnenSprycel · 4.8 · Bleeding Bleeding drug-related adverse reactions, ranging from petechiae and epistaxis to grade 3 or 4 gastroi
Eintrag öffnenSprycel · 4.8 · Bleeding Bleeding drug-related adverse reactions, ranging from petechiae and epistaxis to grade 3 or 4 gastroi
Eintrag öffnenSprycel · 4.8 · CTC grades: neutropaenia (Grade 3 ≥ 0.5– < 1.0 × 109/l, Grade 4 < 0.5 × 109/l); thrombocytopaenia (Grade 3 ≥ 2
Eintrag öffnenSprycel · 4.8 · CTC grades: neutropaenia (Grade 3 ≥ 0.5– < 1.0 × 109/l, Grade 4 < 0.5 × 109/l); thrombocytopaenia (Grade 3 ≥ 2
Eintrag öffnenSprycel · 4.8 · Cardiac adverse reactions Patients with risk factors or a history of cardiac disease should be monitored caref
Eintrag öffnenSprycel · 4.8 · Cardiac adverse reactions Patients with risk factors or a history of cardiac disease should be monitored caref
Eintrag öffnenSprycel · 4.8 · Cumulative grade 3 or 4 cytopaenias among patients treated with 100 mg once daily were similar at 2 and 5 year
Eintrag öffnenSprycel · 4.8 · Cumulative grade 3 or 4 cytopaenias among patients treated with 100 mg once daily were similar at 2 and 5 year
Eintrag öffnenSprycel · 4.8 · Fluid retention Miscellaneous adverse reactions such as pleural effusion, ascites, pulmonary oedema and perica
Eintrag öffnenSprycel · 4.8 · Fluid retention Miscellaneous adverse reactions such as pleural effusion, ascites, pulmonary oedema and perica
Eintrag öffnenSprycel · 4.8 · Hepatitis B reactivation Hepatitis B reactivation has been reported in association with BCR-ABL TKIs. Some cas
Eintrag öffnen